In these patients, who are the majority, suppression of the activity of the renin–angiotensin system by angiotensin-converting enzyme (ACE), or angiotensin II receptor antagonism, is effective in both controlling the BP and reducing the complications of hypertension. The gene discussed is REN; the disease is hypertensive disorder.